nique described in detail elsewhere [5, 6] . A fornix-based conjunctival flap was created, a square 4 × 4 mm scleral flap was prepared, and a 1 × 2 mm trabeculectomy was followed by a peripheral iridectomy. The scleral flap was closed with two single 10-0 nylon monofilament sutures at the corners, while Tenon's capsule and the conjunctival wound were closed separately with running 10-0 nylon sutures. Subconjunctival injections of gentamicin and dexamethasone were delivered 180° from the operation site. Soaking of a Wexel sponge dipped in mitomycin-C 0.04% over the sclera flap was performed for 150 seconds. Meanwhile, an Ahmed valve implant with a polypropylene base plate was inserted using a standard technique. A fornixbased conjunctival flap was created in the superotemporal or superonasal quadrant, and the adjacent recti muscles were identified. The polypropylene body was placed 8 to 10 mm posterior to the corneoscleral limbus and sutured to the globe with 9-0 nylon sutures. The tube was trimmed to the appropriate length and inserted into the anterior chamber at the limbus through a paracentesis site created with a 23-gauge needle. Donor human sclera was trimmed, placed over the tube, and secured to the globe with nylon sutures. The conjunctiva was closed with an 8-0 Vicryl suture. Subconjunctival injections of gentamicin and dexamethasone were delivered 180° from the operation site. No antimetabolite was used during the surgical procedure. Topical antibiotics were prescribed four times a day, and topical steroids were administered for two months postoperatively through a dose-tapering regimen.
During the follow-up period, the uncontrolled glaucoma patients were treated with antiglaucoma medications and digital ocular compression. Transconjunctival needling with 5-f luorouracil or mitomycin-C injections was performed when medical therapy did not reduce the IOP to a level adequate for the individual patient. An EB was defined as an elevated, smooth-surfaced, tense, thickened, dome-shaped fibrotic membrane [1] . EB removal was carried out under local/general anesthesia by an experienced surgeon (CK) when the above-mentioned treatments failed to control the intraocular pressure (IOP) level. The following information was documented for each patient: age, gender, ophthalmologic history, type of glaucoma, time from glaucoma surgery to EB removal, pre-operative treatment, prescribed anti-glaucoma medications, conjunctival flap, and baseline, pre-operative, and post-operative intraocular pressures.
During surgery, the conjunctiva and tenon were dissected, and the EB was then directly opened. The fibrotic capsule was carefully removed along with as much tissue as possible. The wound was then closed using 8-0 vicryl sutures. Immediately after resection, the specimens were fixed in formalin and transferred to the laboratory for further processing. A gross picture of the specimen was taken, and the specimen was then embedded in paraffin and epoxy resin according to standard protocols. The paraffin sections were stained with hematoxylin-eosin, trichrome Masson-Goldner, and alcian blue stains to observe the collagen fibers and to count the number of fibroblasts in the hyperfield area.
Results
In total, we studied three eyes from three patients who underwent trabeculectomy with mitomycin-C and five eyes from four patients who underwent Ahmed valve implantation before the identification of bleb encapsulation. The underlying diagnoses were congenital glaucoma (2 eyes), aphakic glaucoma after retina surgery (1 eye), secondary Fornix  24  28 glaucoma associated with pseudophakia (1 eye), secondary glaucoma associated with Cogan-Reese syndrome (1 eye), secondary glaucoma after penetrating keratoplasty (2 eyes), and neovascular glaucoma (1 eye). The clinical data related to these patients is included in Table 1 . On average, EB removal was performed at 26.6 ± 19.4 weeks after the Ahmed valve implantation procedure and 12.0 ± 11.4 weeks after trabeculectomy with mitomycin C. The mean intraocular pressure of 31.20 ± 5.26 mmHg at diagnosis decreased to 11.80 ± 5.12 mmHg after the removal of the EB in the Ahmed valve implantation group, and 30.67 ± 11.02 mmHg at diagnosis decreased to 9.33 ± 3.06 mmHg postoperatively in the trabeculectomy group. The macroscopic analysis of the excised capsule revealed a white, smooth, coconut flesh-like inner surface and an irregular vascularized outer surface in both groups (Fig. 1) . The capsular wall was thicker in the Ahmed valve implantation group (2.48 ± 0.42 mm) compared to the trabeculectomy group (1.62 ± 0.37 mm). Histopathologically, the subdivision of the tissue was also evident; the vascular structure of the outer layer resembled normal collagenous connective tissue containing small amounts of elastin, and the inner surface consisted of dense collagen fibers with elastoid degeneration (Figs. 2-4 ). An inf lammatory response was nearly absent in all areas of the excised specimen. The ratio of outer fibrovascular layer thickness to inner fibrodegenerative layer thickness was approximately 3 : 1, and there was no difference between the two groups (Fig. 5 ).
Discussion
In a number of surgical cases, EB develop around the antiglaucoma device or scleral flap after glaucoma surgery, requiring further surgical intervention. The process of EB formation is not well understood, but the migration and proliferation of fibroblasts and aqueous humor seem to play a major role in EB formation. Fibroblasts activated by the inflammatory reaction as part of the healing process trigger scar formation, and the occlusion of aqueous humor outflow as a result of excessive inflammation is a major cause of early failure of glaucoma surgery [7] . Also, aqueous humor displacement of interstitial tissue fluid from the inner surface of the bleb capsule may induce gradual cell death followed by collagen fiber swelling, fragmentation, and opening of the intercellular matrix. Scarring of Tenon's capsule localized at the filtration site with a specific dome-shaped, hard appearance associated with IOP elevation were initially reported by Van Buskirk in eight patients who had undergone a variety of filtering operations [1] . In previous studies, the incidence of bleb encapsulation ranged from 2.5% to 29% with various surgical techniques in different types of glaucoma. Comparing these studies, it is important to consider the possible effect of surgical technique on the incidence rate. Factors such as trabeculectomy versus glaucoma device implantation and the use of an antimetabolic agent may influence this rate.
The surgical mechanisms for the two procedures compared in this study are quite different. In trabeculectomy, an aqueous outflow tract is created on the patient's sclera, and an antimetabolic agent is soaked over the area for a few minutes to prevent adhesion between the scleral flap and conjunctival reservoir. On the other hand, a polypropylene base plate and a sheet-like valve without an adjunctive antimetabolic agent are used in the Ahmed glaucoma valve implantation procedure. During insertion, the Ahmed glaucoma valve is fixed to the sclera and covered by the tenon and conjunctiva, forming a filtering bleb far from the limbal region.
The indicated types of glaucoma are also different. Trabeculectomy is the treatment of choice in open angle glaucoma, but the majority of studies involving glaucoma drainage devices include patients with neovascular or uveitic glaucoma.
Thus far, there are only a few published studies on encapsulation in trabeculectomy, and there has not been a comparative study on encapsulation following Ahmed glaucoma valve implantation or trabeculectomy with mitomycin-C [3, 4, 8, 9] . In our study, macroscopic evaluation revealed that the EB was significantly thicker in the Ahmed valve implantation group compared to the trabeculectomy group. On the other hand, the histologic findings of the EB were similar to findings from previous studies [7, 10, 11] . The EB was subdivided into two layers, an outer fibrovascular layer and an inner fibrodegenerative layer with dense collagen fibers. There were no differences in the histologic findings between the two groups, suggesting a common pathophysiologic pathway of EB formation, as is also observed in other healing tissues.
The use of adjunctive mitomycin-C could be the causative factor explaining the difference in capsule wall thickness. mitomycin-C was reported to lower the rate (2.5%) of encapsulation in one series of trabeculectomies [3] . However, Campagna et al. [4] reported a 29% incidence with mitomycin-C in another series of 100 patients. Nevertheless, mitomycin-C may reduce the activity of fibroblasts in the trabeculectomy group and may lead to reductions in EB wall thickness.
Previous data show that the base plate material used in Ahmed implants can play an important role in fibrous tissue formation and may be involved in encapsulation. Polypropylene, which was used in early Ahmed glaucoma base plates, seems to have a higher potency for encapsulation than the later silicone base plates [12] . A polypropylene base plate was used in all patients who underwent Ahmed valve implantation in the present study. The new material was not sufficient for preventing formation of encapsulation, indicating that the base plate material may not be the most important factor in triggering fibrous tissue development.
Further investigations, such as electron microscopy or other special staining techniques, are needed to gain more information about EB. Electron micrographs of connective tissue may give us more precise information of epithelial cells, fibroblasts, and small blood vessels. Activated myofibroblasts and myofibrils within the inner layer, compared with the narrow silent fibrocytes in the outer layer, were reported from electron microscopy following trabeculectomy [11] . Collagen-specific staining like aldehyde fuchsin may show a loss of collagen in the inner layer of the EB, and immunostaining may indicate the activation and transformation of fibroblasts into myofibroblasts in the inner section [10] . 
